Whitefort Capital Management, L.P. is an investment fund managing more than $143 billion ran by Ran Shaham. There are currently 16 companies in Mrs. Shaham’s portfolio. The largest investments include Arbutus Biopharma Corp and Roivant Sciences Ltd, together worth $65 billion.
As of 7th August 2024, Whitefort Capital Management, L.P.’s top holding is 12,867,967 shares of Arbutus Biopharma Corp currently worth over $39.8 billion and making up 27.7% of the portfolio value.
Relative to the number of outstanding shares of Arbutus Biopharma Corp, Whitefort Capital Management, L.P. owns less than approximately 0.1% of the company.
In addition, the fund holds 2,391,000 shares of Roivant Sciences Ltd worth $25.3 billion.
The third-largest holding is Nextnav Inc worth $12.2 billion and the next is Genworth Finl Inc worth $12.1 billion, with 1,996,960 shares owned.
Currently, Whitefort Capital Management, L.P.'s portfolio is worth at least $143 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Whitefort Capital Management, L.P. office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Ran Shaham serves as the Chief Financial Officer at Whitefort Capital Management, L.P..
In the most recent 13F filing, Whitefort Capital Management, L.P. revealed that it had opened a new position in
Arbutus Biopharma Corp and bought 12,867,967 shares worth $39.8 billion.
This means they effectively own approximately 0.1% of the company.
Arbutus Biopharma Corp makes up
79.9%
of the fund's Health Care sector allocation and has grown its share price by 88.1% in the past year.
The investment fund also strengthened its position in Nextnav Inc by buying
1,476,722 additional shares.
This makes their stake in Nextnav Inc total 1,500,654 shares worth $12.2 billion.
On the other hand, there are companies that Whitefort Capital Management, L.P. is getting rid of from its portfolio.
Whitefort Capital Management, L.P. closed its position in Liberty Media on 14th August 2024.
It sold the previously owned 486,411 shares for $17.5 million.
Ran Shaham also disclosed a decreased stake in Global Ship Lease Inc by 0.5%.
This leaves the value of the investment at $10.6 billion and 366,771 shares.
The two most similar investment funds to Whitefort Capital Management, L.P. are Central Asset Investments & Management (hk) Ltd and Prentiss Smith & Co Inc. They manage $143 billion and $143 billion respectively.
Whitefort Capital Management, L.P.’s portfolio is diversified across 6 sectors.
Currently, their heaviest sector is Health Care — making up 34.7% of
the total portfolio value.
The fund focuses on investments in the United States as
31.3% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
6% of the total holdings value.
On the other hand, small-cap stocks make up only 6.3% of the portfolio.
The average market cap of the portfolio companies is close to $2.19 billion.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Arbutus Biopharma Corp |
Opened
12,867,967
|
$39,762,018,000 | 27.73% |
| Roivant Sciences Ltd |
Opened
2,391,000
|
$25,272,870,000 | 17.63% |
| Nextnav Inc |
6,170.49%
1,500,654
|
$12,170,304,000 | 8.49% |
| Genworth Finl Inc |
Opened
1,996,960
|
$12,061,638,000 | 8.41% |
| Global Ship Lease Inc |
50.65%
366,771
|
$10,559,337,000 | 7.36% |
| Liberty Media Corp. |
Opened
456,285
|
$10,111,276,000 | 7.05% |
| Liquidia Corp |
Opened
774,479
|
$9,293,748,000 | 6.48% |
| JOYY Inc |
Opened
210,946
|
$6,347,365,000 | 4.43% |
| Esperion Therapeutics Inc Ne |
Opened
2,299,121
|
$5,104,049,000 | 3.56% |
| Maiden Holdings Ltd |
112.07%
2,048,163
|
$4,219,216,000 | 2.94% |
| Odyssey Marine Expl Inc |
No change
548,909
|
$2,678,676,000 | 1.87% |
| Core Scientific Inc New |
Opened
262,500
|
$2,441,250,000 | 1.70% |
| Pitney Bowes, Inc. |
Opened
373,500
|
$1,897,380,000 | 1.32% |
| Innovate Corp |
54.91%
1,288,917
|
$779,279,000 | 0.54% |
| Opko Health Inc |
Opened
403,190
|
$503,988,000 | 0.35% |
| Trinity Biotech Plc |
Opened
81,902
|
$174,451,000 | 0.12% |
| Liberty Media Corp. |
Closed
486,411
|
$17,535,000 | |
| Renren Inc |
Closed
590,487
|
$17,077,000 | |
| Liberty Media Acquisition Co |
Closed
1,177,823
|
$11,590,000 | |
| SRAX Inc |
Closed
2,476,736
|
$8,223,000 | |
| Trinity Biotech Plc |
Closed
409,517
|
$502,000 | |
| No transactions found | |||
| Showing first 500 out of 21 holdings | |||